Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Codexis has decided to focus exclusively on developing biocatalysts for making pharmaceuticals and specialty chemicals. It is winding down its cellulase enzymes business after failing to find a new transaction or partner in light of slow prospects for the expansion of the cellulosic ethanol industry. Earlier in the year, Codexis also stopped development of detergent alcohols.
This article has been sent to the following recipient: